|
Vol. 273, Issue 1, 194-199, January 2, 1998
Cell Cycle Regulation of Histone H4 Gene Transcription
Requires the Oncogenic Factor IRF-2
Patricia S.
Vaughan ,
Caroline M. J.
van der Meijden ,
Farah
Aziz ,
Hisashi
Harada§,
Tadatsugu
Taniguchi¶,
André J.
van Wijnen ,
Janet L.
Stein , and
Gary S.
Stein
From the Department of Cell Biology and Cancer
Center, University of Massachusetts Medical Center, Worcester,
Massachusetts 01655, the § Division of Molecular Oncology,
Departments of Medicine and Pathology, Washington University School of
Medicine, St. Louis, Missouri 63110, and the ¶ Department of
Immunology, Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku 113, Tokyo
Histone genes display a peak in transcription in
early S phase and are ideal models for cell cycle-regulated gene
expression. We have previously shown that the transcription factor
interferon regulatory factor 2 (IRF-2) can activate histone H4 gene
expression. In this report we establish that a mouse histone H4 gene
and its human homolog lose stringent cell cycle control in synchronized embryonic fibroblasts in which IRF-2 has been ablated. We also show
that there are reduced mRNA levels of this endogenous mouse histone
H4 gene in the IRF-2 / cells. Strikingly, the
overall mRNA level and cell cycle regulation of histone H4
transcription are restored when IRF-2 is reintroduced to these cells.
IRF-2 is a negative regulator of the interferon response and has
oncogenic potential, but little is known of the mechanism of these
activities. Our results suggest that IRF-2 is an active player in
E2F-independent cell cycle-regulated gene expression at the
G1/S phase transition. IRF-2 was previously considered a
passive antagonist to the tumor suppressor IRF-1 but can now join other
oncogenic factors such as c-Myb and E2F1 that are predicted to mediate
their transforming capabilities by actively regulating genes necessary
for cell cycle progression.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Koeppel, S. J. van Heeringen, L. Smeenk, A. C. Navis, E. M. Janssen-Megens, and M. Lohrum
The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response
Nucleic Acids Res.,
February 1, 2009;
37(2):
322 - 335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Dhar, S. Roy, and S. Das
Translational control of the interferon regulatory factor 2 mRNA by IRES element
Nucleic Acids Res.,
August 13, 2007;
(2007)
gkm524v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, D.-P. Liu, P.-P. Chen, H. P. Koeffler, X.-J. Tong, and D. Xie
Involvement of IFN Regulatory Factor (IRF)-1 and IRF-2 in the Formation and Progression of Human Esophageal Cancers
Cancer Res.,
March 15, 2007;
67(6):
2535 - 2543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. M. Nhu, N. Cuesta, and S. N. Vogel
Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2)
Innate Immunity,
October 1, 2006;
12(5):
285 - 295.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Guo, S. Garg, K. M. Hill, L. Jayashankar, M. R. Mooney, M. Hoelscher, J. M. Katz, J. M. Boss, and S. Sambhara
A Distal Regulatory Region Is Required for Constitutive and IFN-{beta}-Induced Expression of Murine TLR9 Gene
J. Immunol.,
December 1, 2005;
175(11):
7407 - 7418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. F. Holmes, C. D. Braastad, P. Mitra, C. Hampe, D. Doenecke, W. Albig, J. L. Stein, A. J. van Wijnen, and G. S. Stein
Coordinate Control and Selective Expression of the Full Complement of Replication-dependent Histone H4 Genes in Normal and Cancer Cells
J. Biol. Chem.,
November 11, 2005;
280(45):
37400 - 37407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-C. Rouyez, M. Lestingi, M. Charon, S. Fichelson, A. Buzyn, and I. Dusanter-Fourt
IFN Regulatory Factor-2 Cooperates with STAT1 to Regulate Transporter Associated with Antigen Processing-1 Promoter Activity
J. Immunol.,
April 1, 2005;
174(7):
3948 - 3958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-C. Chung and S. Kawamoto
IRF-2 Is Involved in Up-regulation of Nonmuscle Myosin Heavy Chain II-A Gene Expression during Phorbol Ester-induced Promyelocytic HL-60 Differentiation
J. Biol. Chem.,
December 31, 2004;
279(53):
56042 - 56052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Ye, Y. Wei, G. Nalepa, and J. W. Harper
The Cyclin E/Cdk2 Substrate p220NPAT Is Required for S-Phase Entry, Histone Gene Expression, and Cajal Body Maintenance in Human Somatic Cells
Mol. Cell. Biol.,
December 1, 2003;
23(23):
8586 - 8600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mitra, R.-L. Xie, R. Medina, H. Hovhannisyan, S. K. Zaidi, Y. Wei, J. W. Harper, J. L. Stein, A. J. van Wijnen, and G. S. Stein
Identification of HiNF-P, a Key Activator of Cell Cycle-Controlled Histone H4 Genes at the Onset of S Phase
Mol. Cell. Biol.,
November 15, 2003;
23(22):
8110 - 8123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-L. Xie, S. Gupta, A. Miele, D. Shiffman, J. L. Stein, G. S. Stein, and A. J. van Wijnen
The Tumor Suppressor Interferon Regulatory Factor 1 Interferes with SP1 Activation to Repress the Human CDK2 Promoter
J. Biol. Chem.,
July 11, 2003;
278(29):
26589 - 26596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Masumi, Y. Yamakawa, H. Fukazawa, K. Ozato, and K. Komuro
Interferon Regulatory Factor-2 Regulates Cell Growth through Its Acetylation
J. Biol. Chem.,
July 3, 2003;
278(28):
25401 - 25407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Childs and S. Goodbourn
Identification of novel co-repressor molecules for Interferon Regulatory Factor-2
Nucleic Acids Res.,
June 15, 2003;
31(12):
3016 - 3026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ohshima, M. Takahashi, and F. Hirose
Identification of a Human Homologue of the DREF Transcription Factor with a Potential Role in Regulation of the Histone H1 Gene
J. Biol. Chem.,
June 13, 2003;
278(25):
22928 - 22938.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Heinz, V. Haehnel, M. Karaghiosoff, L. Schwarzfischer, M. Muller, S. W. Krause, and M. Rehli
Species-specific Regulation of Toll-like Receptor 3 Genes in Men and Mice
J. Biol. Chem.,
June 6, 2003;
278(24):
21502 - 21509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Cuesta, C. A. Salkowski, K. E. Thomas, and S. N. Vogel
Regulation of Lipopolysaccharide Sensitivity by IFN Regulatory Factor-2
J. Immunol.,
June 1, 2003;
170(11):
5739 - 5747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wei, J. Jin, and J. W. Harper
The Cyclin E/Cdk2 Substrate and Cajal Body Component p220NPAT Activates Histone Transcription through a Novel LisH-Like Domain
Mol. Cell. Biol.,
May 15, 2003;
23(10):
3669 - 3680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Barnes, A. E. Field, and P. M. Pitha-Rowe
Virus-induced Heterodimer Formation between IRF-5 and IRF-7 Modulates Assembly of the IFNA Enhanceosome in Vivo and Transcriptional Activity of IFNA Genes
J. Biol. Chem.,
May 2, 2003;
278(19):
16630 - 16641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-L. Xie, A. J. van Wijnen, C. M. van der Meijden, J. L. Stein, and G. S. Stein
Forced Expression of the Interferon Regulatory Factor 2 Oncoprotein Causes Polyploidy and Cell Death in FDC-P1 Myeloid Hematopoietic Progenitor Cells
Cancer Res.,
May 1, 2002;
62(9):
2510 - 2515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Malakhova, M. Malakhov, C. Hetherington, and D.-E. Zhang
Lipopolysaccharide Activates the Expression of ISG15-specific Protease UBP43 via Interferon Regulatory Factor 3
J. Biol. Chem.,
April 19, 2002;
277(17):
14703 - 14711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L.-Y. Chang, A. Mosoian, R. Pine, M. E. Klotman, and J. P. Moore
A Soluble Factor(s) Secreted from CD8+ T Lymphocytes Inhibits Human Immunodeficiency Virus Type 1 Replication through STAT1 Activation
J. Virol.,
January 15, 2002;
76(2):
569 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lohoff, G. S. Duncan, D. Ferrick, H.-W. Mittrucker, S. Bischof, S. Prechtl, M. Rollinghoff, E. Schmitt, A. Pahl, and T. W. Mak
Deficiency in the Transcription Factor Interferon Regulatory Factor (IRF)-2 Leads to Severely Compromised Development of Natural Killer and T Helper Type 1 Cells
J. Exp. Med.,
July 31, 2000;
192(3):
325 - 336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Stein, M. Montecino, A. J. van Wijnen, J. L. Stein, and J. B. Lian
Nuclear Structure-Gene Expression Interrelationships: Implications for Aberrant Gene Expression in Cancer
Cancer Res.,
April 1, 2000;
60(8):
2067 - 2076.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Xie, A. J. van Wijnen, C. van der Meijden, M. X. Luong, J. L. Stein, and G. S. Stein
The Cell Cycle Control Element of Histone H4 Gene Transcription Is Maximally Responsive to Interferon Regulatory Factor Pairs IRF-1/IRF-3 and IRF-1/IRF-7
J. Biol. Chem.,
May 18, 2001;
276(21):
18624 - 18632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Masumi and K. Ozato
Coactivator p300 Acetylates the Interferon Regulatory Factor-2 in U937 Cells following Phorbol Ester Treatment
J. Biol. Chem.,
June 8, 2001;
276(24):
20973 - 20980.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|